SCHEMBL8773146

SCHEMBL8773146

NC(=O)c1cccc(C(=O)O)c1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.51
ALDH1A1 P00352 7/20 0.43
TDP1 Q9NUW8 3/20 0.43
ALOX15 P16050 2/20 0.43
CYP3A4 P08684 1/20 0.43
KDM4E B2RXH2 3/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TP53 P04637 1/20 0.42
G6PD P11413 1/20 0.41
CASP7 P55210 1/20 0.41
CASP6 P55212 1/20 0.41
MMP2 P08253 1/20 0.41
BCAT2 O15382 1/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792626 0.94 TSHR (0.48) TSHRALDH1A1TDP1CYP3A4KDM4E
SCHEMBL1497989 0.90 TSHR (0.60) TSHRALDH1A1TDP1ALOX15CYP3A4
SCHEMBL27771692 0.88 TSHR (0.58) TSHRALDH1A1TDP1ALOX15CYP3A4
SCHEMBL28171346 0.88 TSHR (0.58) TSHRALDH1A1TDP1ALOX15CYP3A4
SCHEMBL30490414 0.88 TSHR (0.58) TSHRALDH1A1TDP1ALOX15CYP3A4
Ethylene SCHEMBL29290025 0.86 TSHR (0.56) TSHRALDH1A1TDP1ALOX15CYP3A4
SCHEMBL3295168 0.83 TSHR (0.43) TSHRALDH1A1TDP1ALOX15CYP3A4
SCHEMBL30682787 0.83 TSHR (0.43) TSHRALDH1A1TDP1ALOX15CYP3A4
SCHEMBL366798 0.83 GPR35 (0.56) TSHRALDH1A1TDP1CYP3A4KDM4E
Ethylene Glycol SCHEMBL29290024 0.82 TSHR (0.53) TSHRALDH1A1TDP1ALOX15CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9981925-B2 Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors MERCK PATENT GMBH (DE) 2018-05-29 US disclosed
US-20160340323-A1 AZAQUINAZOLINE CARBOXAMIDE DERIVATIVES MERCK PATENT GMBH (DE) 2016-11-24 US disclosed
US-20160340323-A1 AZAQUINAZOLINE CARBOXAMIDE DERIVATIVES MERCK PATENT GMBH (DE) 2016-11-24 US disclosed
EP-0791004-A1 ACYLATED BENZYLGLYCOSIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION AMERICAN HOME PRODUCTS CORPORATION (US) 1997-08-27 EP disclosed
WO-1996014325-A1 ACYLATED BENZYLGLYCOSIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION AMERICAN HOME PRODUCTS CORPORATION (US) 1996-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340323-A1 AZAQUINAZOLINE CARBOXAMIDE DERIVATIVES RPS6KA3, RPS6KA4, CDK4 TSHR 2532/4885ALDH1A1 3527/4885TDP1 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.